About Technology Issues FAQ

Links

Official Page

Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436)

Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436) — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.